| PERIOD ENDING | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | 30-Jun-08 | | Total Revenue | 435,184 | 411,486 | 461,632 | 424,533 | | Cost of Revenue |
-
|
-
|
-
|
-
| | | Gross Profit | 435,184 | 411,486 | 461,632 | 424,533 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 682,048 | 838,331 | 224,384 | 1,020,523 | | Non Recurring |
-
|
-
| 422,679 | (422,679) | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (246,864) | (426,845) | (185,431) | (173,311) | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
| (21,134) | 11,157 | | Earnings Before Interest And Taxes | (246,864) | (426,845) | (185,431) | (173,321) | | Interest Expense | 23,926 | 20,240 | 20,119 | 19,891 | | Income Before Tax | (270,790) | (447,085) | (205,550) | (193,212) | | Income Tax Expense | (86,230) | (173,738) | (88,924) | (84,146) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (184,560) | (273,347) | (113,274) | (97,899) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (184,560) | (273,347) | (113,274) | (97,899) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($184,560) | ($273,347) | ($113,274) | ($97,899) |
|
0.45% Nasdaq 
0.20%
Income Statement
